Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Agatha A. van der Schaaf"'
Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer
Autor:
Diana J. Hastrich, Tony Barham, David Joseph, Bruce Latham, Andrew Redfern, Jacqui Thomson, David Ingram, Agatha A van der Schaaf, James H. Anderson, Peter C. Willsher, Arlene Chan
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 8:62-70
Aims: To assess the feasibility of a standardized multidisciplinary protocol for the management of locally advanced breast cancer (LABC). We also evaluated the accuracy of magnetic resonance imaging (MRI) and positron emission tomography (PET) in pre
Autor:
Jan Boucek, Roslyn J. Francis, Peter Robins, Anna K. Nowak, Amanda Segal, Michael J. Byrne, Arthur W. Musk, Michael Millward, Michael Phillips, Melanie J. McCoy, Agatha A. van der Schaaf
Publikováno v:
Clinical Cancer Research. 16:2409-2417
Purpose: Existing prognostic systems for malignant pleural mesothelioma do not incorporate imaging information. We aimed to identify the contribution of quantitative fluorodeoxyglucose positron emission tomography (FDG-PET) analysis to other prognost
Autor:
A. William Musk, Michael Millward, Michael Phillips, Michael J. Byrne, Roslyn J. Francis, Richard W. Price, Andrew P. Patrikeos, Jan Boucek, Anna K. Nowak, Agatha A. van der Schaaf
Publikováno v:
Journal of Nuclear Medicine. 48:1449-1458
The aim of chemotherapy for mesothelioma is to palliate symptoms and improve survival. Measuring response using CT is challenging because of the circumferential tumor growth pattern. This study aims to evaluate the role of serial (18)F-FDG PET in the
Autor:
Michael Millward, Jenette Creaney, Amanda Segal, Anna K. Nowak, Roslyn J. Francis, Michael J. Byrne, Ian M. Dick, Agatha A. van der Schaaf, Arthur W. Musk, Arman Hasani
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 7(9)
Introduction: There is no accepted second-line therapy for patients with advanced malignant pleural mesothelioma (MPM), whose disease has progressed after first-line chemotherapy. The multitargeted tyrosine kinase inhibitor sunitinib malate targets s
Autor:
Alex K Cohen, Agatha A van der Schaaf
Publikováno v:
Medical Journal of Australia. 176:570-571
Publikováno v:
Internal Medicine Journal; Jul2006 Supplement, Vol. 36, pA99-A136, 37p, 5 Diagrams, 10 Charts, 2 Graphs
Publikováno v:
European Journal of Nuclear Medicine; Dec1990, Vol. 16 Issue 12, p855-858, 4p
Publikováno v:
Heart; Oct97, Vol. 78 Issue 4, p346, 7p, 1 Diagram, 6 Charts